Juul Labs was once the high-flying, market dominating company that fueled a global e-cigarette boom—and with it a teenage nicotine epidemic. Today, the company is under siege amid thousands of lawsuits accusing it of marketing to underage users, potential government regulations, and widespread health concerns about its vaping products. The biggest threat to staying in business is an upcoming FDA ruling on whether Juul’s devices and nicotine pods have enough public health benefit to continue selling them in the U.S. Major health organizations have asked the agency to reject the application, fearing it would lay the groundwork for the company to expand its reach once again. Meanwhile, there is continuing debate over the decision by the World Anti-Doping Agency to disqualify American track star Sha’Carri Richardson from the upcoming Tokyo Olympics after she tested positive for marijuana. The drug is on the list of the agency’s prohibited substances, because it can be performance enhancing, and negatively effect hand-eye coordination, concentration and endurance, according to the agency. Some say the rules should be changed to allow athletes to consume cannabis products, as they are now legal in many states and countries. And finally, pundits are speculating that the Sha’Carri Richardson pot scandal may be mellowing President Biden’s views on marijuana. Commenting on the suspension, Biden praised the athlete on the way she responded to the decision, but said “rules are rules.” Then he seemed to leave the door open to change, adding, “whether [the rules] should remain that way is a different issue.” Biden has been more cautious about marijuana legalization than many fellow Democrats and has not endorsed lifting the federal prohibition on pot, while saying states should be able to go their own way.